BOOK
Volume 5, Issue 1, An Issue of Hospital Medicine Clinics, E-Book
Jeffrey Glasheen | Mary Anderson
(2015)
Additional Information
Book Details
Abstract
This online Clinics series provides evidence-based answers to clinical questions the practicing hospitalist faces daily. Now entering the fifth volume year of our growing online database, this issue edited by Jeff Glasheen and Mary Anderson, covers essential updates in the following topics: Vascular Access for Hospitalized Patients ,Mechanical and Noninvasive Ventilation,Isolation Precautions,Nephrolithiasis,Fecal Microbiota Transplant, Regional Anesthesia (Peripheral Nerve Blocks and Epidurals),Chemotherapy and Biologic/Targeted Therapies, Procedural Skills for the Hospitalist, Palliative Sedation, and Patient Experience.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Contributors | A1 | ||
CONSULTING EDITOR | A1 | ||
EDITORS | A1 | ||
AUTHORS | A1 | ||
Contents | A4 | ||
Preface: A Hospital Away from Home | A4 | ||
Vascular Access in Hospitalized Patients | A4 | ||
Invasive Mechanical Ventilation | A4 | ||
Isolation Precautions in the Inpatient Setting | A4 | ||
Nephrolithiasis | A5 | ||
Fecal Microbiota Transplant | A5 | ||
Regional Anesthesia | A5 | ||
Chemotherapy Basics for Hospitalists | A5 | ||
Palliative Sedation Therapy | A5 | ||
Procedural Skills for Hospitalists | A6 | ||
Patient Experience | A6 | ||
HOSPITAL MEDICINE CLINICS | A7 | ||
FORTHCOMING ISSUES | A7 | ||
April 2016 | A7 | ||
July 2016 | A7 | ||
October 2016 | A7 | ||
RECENT ISSUES | A7 | ||
October 2015 | A7 | ||
July 2015 | A7 | ||
April 2015 | A7 | ||
Preface: A Hospital Away from Home | A8 | ||
Vascular Access in Hospitalized Patients | 1 | ||
DEFINITIONS | 2 | ||
EPIDEMIOLOGY | 2 | ||
PERIPHERAL INTRAVENOUS ACCESS | 2 | ||
Peripheral Intravenous Catheters | 2 | ||
Midline Catheters | 2 | ||
CENTRAL VENOUS ACCESS | 5 | ||
Nontunneled Catheters | 5 | ||
Tunneled Catheters | 5 | ||
Subcutaneous Ports | 7 | ||
Peripherally Inserted Central Catheters | 8 | ||
Introducer Sheaths | 8 | ||
INTRAOSSEOUS ACCESS | 12 | ||
PERFORMANCE IMPROVEMENT | 13 | ||
CLINICAL GUIDELINES | 14 | ||
REFERENCES | 14 | ||
Invasive Mechanical Ventilation | 17 | ||
EPIDEMIOLOGY | 18 | ||
INDICATIONS/CONTRAINDICATIONS | 18 | ||
APPROACH TO MECHANICAL VENTILATION | 18 | ||
Procedure Logistics | 18 | ||
Volume control versus pressure control | 19 | ||
Pressure support/continuous spontaneous ventilation | 20 | ||
Pressure-regulated volume control | 20 | ||
Airway pressure release ventilation | 20 | ||
Tidal volume | 21 | ||
TROUBLESHOOTING | 23 | ||
PERFORMANCE IMPROVEMENT | 25 | ||
CLINICAL GUIDELINES | 25 | ||
REFERENCES | 26 | ||
Isolation Precautions in the Inpatient Setting | 30 | ||
DEFINITIONS | 31 | ||
EPIDEMIOLOGY | 32 | ||
TRANSMISSION-BASED PRECAUTIONS | 32 | ||
Droplet Precautions | 32 | ||
Airborne Precautions | 35 | ||
Contact Precautions | 37 | ||
PERFORMANCE IMPROVEMENT/IMPLICATIONS | 39 | ||
CLINICAL GUIDELINES | 41 | ||
REFERENCES | 41 | ||
Nephrolithiasis | 43 | ||
DEFINITIONS | 44 | ||
EPIDEMIOLOGY | 44 | ||
HISTORY AND EXAMINATION | 46 | ||
DIAGNOSIS | 48 | ||
MANAGEMENT | 50 | ||
PERFORMANCE IMPROVEMENT | 54 | ||
CLINICAL GUIDELINES | 55 | ||
REFERENCES | 56 | ||
Fecal Microbiota Transplant | 58 | ||
HISTORY IN MEDICINE | 59 | ||
EPIDEMIOLOGY | 59 | ||
INDICATIONS/CONTRAINDICATIONS | 60 | ||
PATIENT AND DONOR PREPARATION | 60 | ||
PREPROCEDURE PREPARATION | 62 | ||
APPROACH AND DELIVERY | 64 | ||
Nasoenteric Tube | 64 | ||
Upper Endoscopy | 64 | ||
Retention Enema | 64 | ||
Colonoscopy | 64 | ||
Oral Capsules | 65 | ||
OUTCOMES AND EVIDENCE | 65 | ||
REDUCING COMPLICATIONS | 66 | ||
PERFORMANCE IMPROVEMENT | 67 | ||
CLINICAL GUIDELINES | 67 | ||
REFERENCES | 67 | ||
Regional Anesthesia | 71 | ||
INTRODUCTION | 71 | ||
DEFINITIONS | 72 | ||
EPIDEMIOLOGY | 72 | ||
MEDICATION SELECTION | 73 | ||
INDICATIONS/CONTRAINDICATIONS | 74 | ||
PERIPROCEDURE CARE | 76 | ||
REDUCING COMPLICATIONS | 77 | ||
PERFORMANCE IMPROVEMENT | 81 | ||
CLINICAL GUIDELINES | 82 | ||
REFERENCES | 82 | ||
Chemotherapy Basics for Hospitalists | 85 | ||
DEFINITIONS | 85 | ||
EPIDEMIOLOGY | 87 | ||
TYPES OF CHEMOTHERAPY DRUGS | 88 | ||
Alkylating Agents | 88 | ||
ANTIMETABOLITES | 89 | ||
Antitumor Antibiotics | 90 | ||
TOPOISOMERASE INHIBITORS | 91 | ||
MITOTIC INHIBITORS | 91 | ||
COMMON CHEMOTHERAPY REGIMENS | 92 | ||
ENDOCRINE THERAPY | 93 | ||
TARGETED THERAPIES | 94 | ||
IMMUNOTHERAPY | 94 | ||
MANAGEMENT OF COMPLICATIONS | 96 | ||
PERFORMANCE IMPROVEMENT | 98 | ||
CLINICAL GUIDELINES | 98 | ||
REFERENCES | 98 | ||
Palliative Sedation Therapy | 101 | ||
CLINICAL GUIDELINES | 102 | ||
Definition | 102 | ||
PREVALENCE | 104 | ||
OUTCOMES AND EVIDENCE | 105 | ||
ETHICS AND LEGAL ISSUES | 105 | ||
PALLIATIVE SEDATION PROCEDURE | 108 | ||
Preparation | 108 | ||
APPROACH | 109 | ||
PERFORMANCE IMPROVEMENT | 112 | ||
REFERENCES | 112 | ||
Procedural Skills for Hospitalists | 114 | ||
BACKGROUND | 115 | ||
ABDOMINAL PARACENTESIS | 115 | ||
TECHNIQUE PEARLS | 118 | ||
Summary of Billing Codes | 120 | ||
THORACENTESIS | 120 | ||
TECHNIQUE PEARLS | 123 | ||
LUMBAR PUNCTURE | 124 | ||
TECHNIQUE PEARLS | 128 | ||
Using Ultrasonography in Lumbar Puncture | 130 | ||
ARTHROCENTESIS | 130 | ||
TECHNIQUE PEARLS | 132 | ||
Using the Ultrasonography for Arthrocentesis | 132 | ||
PERFORMANCE IMPROVEMENT | 133 | ||
REFERENCES | 134 | ||
Patient Experience | 137 | ||
KEY PRINCIPLES | 137 | ||
Defining Patient Experience | 138 | ||
Frameworks for Patient Experience | 138 | ||
GUIDELINES FOR PRACTICE | 144 | ||
Understanding what Patients Care About Most | 144 | ||
Enhancing the Patient Communication Toolkit for Providers | 145 | ||
Other Tools to Enhance Patient Experience | 145 | ||
Whiteboards | 145 | ||
Face cards | 145 | ||
Digital tools | 146 | ||
Seeking Actionable Feedback | 146 | ||
Taking a Leadership Role in Health Systems Redesign in Hospitals | 147 | ||
REFERENCES | 147 |